This site uses cookies to deliver our services and to show you relevant ads and presentations. By clicking on "Accept", you acknowledge that you have read and understand our Cookie Policy , Privacy Policy , and our Terms of Use.
X

Download Diabetes Care PowerPoint Presentation


Login   OR  Register
X


Iframe embed code :



Presentation url :

X

Description :

View and free download Diabetes Care powerpoint presentation which is uploaded by search an active user in belonging ppt presentation Health & Wellness category.

Tags :

Diabetes Care

Home / Health & Wellness / Health & Wellness Presentations / Diabetes Care PowerPoint Presentation

Diabetes Care PowerPoint Presentation

Ppt Presentation Embed Code   Zoom Ppt Presentation

About This Presentation


Description : View and free download Diabetes Care powerpoint presentation which is uploaded by search an active u... Read More

Tags : Diabetes Care

Published on : Dec 06, 2013
Views : 602 | Downloads : 1


Download Now

Share on Social Media

           

PowerPoint is the world's most popular presentation software which can let you create professional Diabetes Care powerpoint presentation easily and in no time. This helps you give your presentation on Diabetes Care in a conference, a school lecture, a business proposal, in a webinar and business and professional representations.

The uploader spent his/her valuable time to create this Diabetes Care powerpoint presentation slides, to share his/her useful content with the world. This ppt presentation uploaded by onlinesearch in Health & Wellness ppt presentation category is available for free download,and can be used according to your industries like finance, marketing, education, health and many more.

SlidesFinder.com provides a platform to marketers, presenters and educationists along with being the preferred search engine for professional PowerPoint presentations on the Internet to upload their Diabetes Care ppt presentation slides to help them BUILD THEIR CROWD!!

Slide 1 - The Hyperglycemia and Adverse Pregnancy Outcome Study Featured Article: Patrick M. Catalano, M.D., H. David McIntyre, M.D., J. Kennedy Cruickshank, M.D., David R. McCance, M.D., Alan R. Dyer, Ph.D., Boyd E. Metzger, M.D., Lynn P. Lowe, Ph.D., Elisabeth R. Trimble, M.D., Donald R. Coustan, M.D., David R. Hadden, M.D., Bengt Persson, M.D. Ph.D., Moshe Hod, M.D., Jeremy J.N. Oats, M.D., For the Hapo Study Cooperative Research Group Diabetes Care Volume 35: 780-786 April, 2012
Slide 2 - The Hyperglycemia and Adverse Pregnancy Outcome Study Featured Article: Patrick M. Catalano, M.D., H. David McIntyre, M.D., J. Kennedy Cruickshank, M.D., David R. McCance, M.D., Alan R. Dyer, Ph.D., Boyd E. Metzger, M.D., Lynn P. Lowe, Ph.D., Elisabeth R. Trimble, M.D., Donald R. Coustan, M.D., David R. Hadden, M.D., Bengt Persson, M.D. Ph.D., Moshe Hod, M.D., Jeremy J.N. Oats, M.D., For the Hapo Study Cooperative Research Group Diabetes Care Volume 35: 780-786 April, 2012 Study Objective To determine associations of gestational diabetes mellitus (GDM) and obesity with adverse pregnancy outcomes in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Catalano P et al. Diabetes Care 2012;35:780-786
Slide 3 - The Hyperglycemia and Adverse Pregnancy Outcome Study Featured Article: Patrick M. Catalano, M.D., H. David McIntyre, M.D., J. Kennedy Cruickshank, M.D., David R. McCance, M.D., Alan R. Dyer, Ph.D., Boyd E. Metzger, M.D., Lynn P. Lowe, Ph.D., Elisabeth R. Trimble, M.D., Donald R. Coustan, M.D., David R. Hadden, M.D., Bengt Persson, M.D. Ph.D., Moshe Hod, M.D., Jeremy J.N. Oats, M.D., For the Hapo Study Cooperative Research Group Diabetes Care Volume 35: 780-786 April, 2012 Study Objective To determine associations of gestational diabetes mellitus (GDM) and obesity with adverse pregnancy outcomes in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Catalano P et al. Diabetes Care 2012;35:780-786 Study Design Participants underwent a 75-g OGTT between 24 and 32 weeks   GDM diagnosed post hoc using IADPSG criteria   Neonatal anthropometrics and cord serum C-peptide were measured   Adverse pregnancy outcomes included birth weight, newborn percent body fat, and cord C-peptide >90th percentiles, primary cesarean delivery, preeclampsia, and shoulder dystocia/birth injury   Multiple logistic regression used to examine associations of GDM and obesity with outcomes Catalano P et al. Diabetes Care 2012;35:780-786
Slide 4 - The Hyperglycemia and Adverse Pregnancy Outcome Study Featured Article: Patrick M. Catalano, M.D., H. David McIntyre, M.D., J. Kennedy Cruickshank, M.D., David R. McCance, M.D., Alan R. Dyer, Ph.D., Boyd E. Metzger, M.D., Lynn P. Lowe, Ph.D., Elisabeth R. Trimble, M.D., Donald R. Coustan, M.D., David R. Hadden, M.D., Bengt Persson, M.D. Ph.D., Moshe Hod, M.D., Jeremy J.N. Oats, M.D., For the Hapo Study Cooperative Research Group Diabetes Care Volume 35: 780-786 April, 2012 Study Objective To determine associations of gestational diabetes mellitus (GDM) and obesity with adverse pregnancy outcomes in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Catalano P et al. Diabetes Care 2012;35:780-786 Study Design Participants underwent a 75-g OGTT between 24 and 32 weeks   GDM diagnosed post hoc using IADPSG criteria   Neonatal anthropometrics and cord serum C-peptide were measured   Adverse pregnancy outcomes included birth weight, newborn percent body fat, and cord C-peptide >90th percentiles, primary cesarean delivery, preeclampsia, and shoulder dystocia/birth injury   Multiple logistic regression used to examine associations of GDM and obesity with outcomes Catalano P et al. Diabetes Care 2012;35:780-786 Catalano P et al. Diabetes Care 2012;35:780-786
Slide 5 - The Hyperglycemia and Adverse Pregnancy Outcome Study Featured Article: Patrick M. Catalano, M.D., H. David McIntyre, M.D., J. Kennedy Cruickshank, M.D., David R. McCance, M.D., Alan R. Dyer, Ph.D., Boyd E. Metzger, M.D., Lynn P. Lowe, Ph.D., Elisabeth R. Trimble, M.D., Donald R. Coustan, M.D., David R. Hadden, M.D., Bengt Persson, M.D. Ph.D., Moshe Hod, M.D., Jeremy J.N. Oats, M.D., For the Hapo Study Cooperative Research Group Diabetes Care Volume 35: 780-786 April, 2012 Study Objective To determine associations of gestational diabetes mellitus (GDM) and obesity with adverse pregnancy outcomes in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Catalano P et al. Diabetes Care 2012;35:780-786 Study Design Participants underwent a 75-g OGTT between 24 and 32 weeks   GDM diagnosed post hoc using IADPSG criteria   Neonatal anthropometrics and cord serum C-peptide were measured   Adverse pregnancy outcomes included birth weight, newborn percent body fat, and cord C-peptide >90th percentiles, primary cesarean delivery, preeclampsia, and shoulder dystocia/birth injury   Multiple logistic regression used to examine associations of GDM and obesity with outcomes Catalano P et al. Diabetes Care 2012;35:780-786 Catalano P et al. Diabetes Care 2012;35:780-786 Catalano P et al. Diabetes Care 2012;35:780-786
Slide 6 - The Hyperglycemia and Adverse Pregnancy Outcome Study Featured Article: Patrick M. Catalano, M.D., H. David McIntyre, M.D., J. Kennedy Cruickshank, M.D., David R. McCance, M.D., Alan R. Dyer, Ph.D., Boyd E. Metzger, M.D., Lynn P. Lowe, Ph.D., Elisabeth R. Trimble, M.D., Donald R. Coustan, M.D., David R. Hadden, M.D., Bengt Persson, M.D. Ph.D., Moshe Hod, M.D., Jeremy J.N. Oats, M.D., For the Hapo Study Cooperative Research Group Diabetes Care Volume 35: 780-786 April, 2012 Study Objective To determine associations of gestational diabetes mellitus (GDM) and obesity with adverse pregnancy outcomes in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Catalano P et al. Diabetes Care 2012;35:780-786 Study Design Participants underwent a 75-g OGTT between 24 and 32 weeks   GDM diagnosed post hoc using IADPSG criteria   Neonatal anthropometrics and cord serum C-peptide were measured   Adverse pregnancy outcomes included birth weight, newborn percent body fat, and cord C-peptide >90th percentiles, primary cesarean delivery, preeclampsia, and shoulder dystocia/birth injury   Multiple logistic regression used to examine associations of GDM and obesity with outcomes Catalano P et al. Diabetes Care 2012;35:780-786 Catalano P et al. Diabetes Care 2012;35:780-786 Catalano P et al. Diabetes Care 2012;35:780-786 Catalano P et al. Diabetes Care 2012;35:780-786
Slide 7 - The Hyperglycemia and Adverse Pregnancy Outcome Study Featured Article: Patrick M. Catalano, M.D., H. David McIntyre, M.D., J. Kennedy Cruickshank, M.D., David R. McCance, M.D., Alan R. Dyer, Ph.D., Boyd E. Metzger, M.D., Lynn P. Lowe, Ph.D., Elisabeth R. Trimble, M.D., Donald R. Coustan, M.D., David R. Hadden, M.D., Bengt Persson, M.D. Ph.D., Moshe Hod, M.D., Jeremy J.N. Oats, M.D., For the Hapo Study Cooperative Research Group Diabetes Care Volume 35: 780-786 April, 2012 Study Objective To determine associations of gestational diabetes mellitus (GDM) and obesity with adverse pregnancy outcomes in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Catalano P et al. Diabetes Care 2012;35:780-786 Study Design Participants underwent a 75-g OGTT between 24 and 32 weeks   GDM diagnosed post hoc using IADPSG criteria   Neonatal anthropometrics and cord serum C-peptide were measured   Adverse pregnancy outcomes included birth weight, newborn percent body fat, and cord C-peptide >90th percentiles, primary cesarean delivery, preeclampsia, and shoulder dystocia/birth injury   Multiple logistic regression used to examine associations of GDM and obesity with outcomes Catalano P et al. Diabetes Care 2012;35:780-786 Catalano P et al. Diabetes Care 2012;35:780-786 Catalano P et al. Diabetes Care 2012;35:780-786 Catalano P et al. Diabetes Care 2012;35:780-786 Conclusions   Both maternal GDM and obesity are independently associated with adverse pregnancy outcomes   Their combination has a greater impact than either one alone Catalano P et al. Diabetes Care 2012;35:780-786